PLX
Protalix BioTherapeutics, Inc.Company with tickers: PLX
Market Cap
$176.85M
Shares Outstanding
80,571,642
CIK
1006281
CUSIP
74365A309
13F Activity (30d)
2 filings
1 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.